» Articles » PMID: 11877488

Rapid Cytotoxic T Lymphocyte Activation Occurs in the Draining Lymph Nodes After Cutaneous Herpes Simplex Virus Infection As a Result of Early Antigen Presentation and Not the Presence of Virus

Overview
Journal J Exp Med
Date 2002 Mar 6
PMID 11877488
Citations 73
Authors
Affiliations
Soon will be listed here.
Abstract

Localized cutaneous herpes simplex virus type 1 (HSV-1) infection leads to arming and initial expansion of cytotoxic T lymphocytes (CTLs) in the draining popliteal lymph nodes (PLNs) followed by migration and further proliferation in the spleen. To accurately characterize the sequence of events involved in the activation and generation of anti-HSV CTLs, we used T cell receptor (TCR) transgenic mice specific for the immunodominant epitope from HSV glycoprotein B (gB(498-505)). We describe the detection of the initiation of antigen presentation in the draining lymph nodes by 4-6 h after infection with HSV-1. Analysis of CD69 up-regulation revealed activation of gB-specific CD8(+) T cells by 6-8 h after infection. Furthermore, we show that T cell proliferation begins no sooner than 24 h after activation and is marked by the concurrent appearance of CTL activity in the PLNs. These events are not dependent on the presence of virus in the draining lymph nodes, and suggest a requirement for recruitment of professional antigen-presenting cells to the site of T cell activation. Consequently, we have defined the initiation of the CD8(+) T cell-mediated response to cutaneous HSV-1 infection, demonstrating that the immune response to localized viral infection depends only on the appearance of cells presenting virus-derived antigen and commences with remarkable swiftness.

Citing Articles

T Cell Surveillance during Cutaneous Viral Infections.

Pei L, Hickman H Viruses. 2024; 16(5).

PMID: 38793562 PMC: 11126121. DOI: 10.3390/v16050679.


DOCK2 Deficiency Causes Defects in Antiviral T-Cell Responses and Impaired Control of Herpes Simplex Virus Infection.

Randall K, Flesch I, Mei Y, Miosge L, Aye R, Yu Z J Infect Dis. 2024; 230(3):e712-e721.

PMID: 38366567 PMC: 11420714. DOI: 10.1093/infdis/jiae077.


Prophylactic Vaccination and Intratumoral Boost with HER2-Expressing Oncolytic Herpes Simplex Virus Induces Robust and Persistent Immune Response against HER2-Positive Tumor Cells.

Delwar Z, Tatsiy O, Chouljenko D, Lee I, Liu G, Liu X Vaccines (Basel). 2023; 11(12).

PMID: 38140209 PMC: 10747554. DOI: 10.3390/vaccines11121805.


Small Noncoding RNA (sncRNA1) within the Latency-Associated Transcript Modulates Herpes Simplex Virus 1 Virulence and the Host Immune Response during Acute but Not Latent Infection.

Tormanen K, Matundan H, Wang S, Jaggi U, Mott K, Ghiasi H J Virol. 2022; 96(7):e0005422.

PMID: 35254102 PMC: 9006899. DOI: 10.1128/jvi.00054-22.


Noncognate Signals Drive Enhanced Effector CD8 T Cell Responses through an IFNAR1-Dependent Pathway after Infection with the Prototypic Vaccine, 0ΔNLS, against Herpes Simplex Virus 1.

Gmyrek G, Predki P, Gershburg E, Carr D J Virol. 2022; 96(6):e0172421.

PMID: 35045268 PMC: 8941882. DOI: 10.1128/JVI.01724-21.


References
1.
Salio M, Cella M, Suter M, Lanzavecchia A . Inhibition of dendritic cell maturation by herpes simplex virus. Eur J Immunol. 1999; 29(10):3245-53. DOI: 10.1002/(SICI)1521-4141(199910)29:10<3245::AID-IMMU3245>3.0.CO;2-X. View

2.
McNally J, Dempsey D, Wolcott R, Chervenak R, Jennings S . Phenotypic identification of antigen-dependent and antigen-independent CD8 CTL precursors in the draining lymph node during acute cutaneous herpes simplex virus type 1 infection. J Immunol. 1999; 163(2):675-81. View

3.
Weeks B, Ramchandran R, HOPKINS J, Friedman H . Herpes simplex virus type-1 and -2 pathogenesis is restricted by the epidermal basement membrane. Arch Virol. 2001; 145(2):385-96. DOI: 10.1007/s007050050030. View

4.
Gett A, Hodgkin P . A cellular calculus for signal integration by T cells. Nat Immunol. 2001; 1(3):239-44. DOI: 10.1038/79782. View

5.
Sano G, Hafalla J, Morrot A, Abe R, Lafaille J, Zavala F . Swift development of protective effector functions in naive CD8(+) T cells against malaria liver stages. J Exp Med. 2001; 194(2):173-80. PMC: 2193458. DOI: 10.1084/jem.194.2.173. View